Fundraising FoxAurealis Therapeutics
1 known investors
Find your way into Aurealis Therapeutics
Sign up to see every warm intro you have to Aurealis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aurealis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aurealis Therapeutics is a clinical-stage synthetic biology company developing multi-targeting cell and gene therapies for chronic wounds, cancers, and inflammatory diseases. Its platform targets conditions such as diabetic foot ulcers, venous leg ulcers, and ovarian, peritoneal, bladder, and recurrent melanoma cancers.
Founders & leadership
JY
Juha YrjänheikkiCEO
LD
Laurent DécoryCOO
HP
Hanna P. LeschChief Technology Officer
Investors · 1
Frequently asked questions
- What does Aurealis Therapeutics do?
- Aurealis Therapeutics is a clinical-stage synthetic biology company developing multi-targeting cell and gene therapies for chronic wounds, cancers, and inflammatory diseases. Its platform targets conditions such as diabetic foot ulcers, venous leg ulcers, and ovarian, peritoneal, bladder, and recurrent melanoma cancers.
- Who are Aurealis Therapeutics's investors?
- Aurealis Therapeutics's investors include Tesi (Finnish Industry Investment Ltd).